Seth Kiernan 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Seth Kiernan
VP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+5,286→ 41,986 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−22,963→ 45,927 total→ Common Stock (22,963 underlying) - Exercise/Conversion
Common Stock
2023-02-28+14,833→ 36,700 total - Exercise/Conversion
Common Stock
2023-02-28+22,963→ 64,949 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−14,833→ 0 total→ Common Stock (14,833 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−11,813$25,634→ 53,136 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−5,286→ 5,287 total→ Common Stock (5,286 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.